Funding for global health R&D in 2024
An overview of key takeaways from the G-FINDER survey
Hubs
The Investment Landscape Hub
Powered by G-FINDER, this hub is your go-to resource for data and analysis on the funding landscape for global health R&D. This is where you'll find all the G-FINDER reports across neglected disease, emerging infectious diseases and sexual & reproductive health.
Hub Editors
Dr Paul Barnsley
Research and Analysis Lead
Dr Sabastine Wakdok
Director of Research
Mapping the landscape
What is impacting global health?
Every year the G-FINDER project delivers the latest comprehensive data on global investment into R&D of new products to prevent, diagnose, control or cure diseases which kill millions. We analyse the funding landscape to show you where the money is coming from and where it's going. We reveal areas of growth, areas of decline and where we have gaps. We track which products have entered or moved along the pipeline thanks to this investment. This hub collates this huge resource of data and analysis in one place, where you can explore the findings and assess the implications.
The 2024 G-FINDER Neglected Disease R&D report63%
of global funding came from governments in 2023
Which is a record low
83%
of global philanthropic investment in 2023
Is from the Gates Foundation
12%
of the global vaccine funding in 2023 is for TB
Up from 5% in 2018
Spotlight on latest reports
Relied on by governments, NGOs, private and philanthropic funders, product developers and global health advocates worldwide to inform decisions on R&D funding.
Read more
Mapping the Australian landscape for global health research
This is an in-depth analysis of Australia’s public sector funding for global health research from 2017 to 2023. As a high-income country, Australia has the potential to play a...
Is this the new era? Funding for sexual & reproductive health R&D 2018-2023
This is the fourth in a series of reports summarising the state of global funding for LMIC-applicable biomedical research and development targeting a range of sexual &...
Smart Decisions: The G-FINDER 2024 Neglected Disease R&D report
Tough choices in global health need people who will make smart decisions. This report provides strong data and solid insights to empower the community.
Watch the launch of Is this the new era?
Online webinar held 17 June 2025
Watch the recording of the report launch event where we reflect on the critical trends, gaps, and opportunities to shape the future of SRH and women's health innovation. Our guest speaker was Dr Nigina Muntean, Chief of the Innovation and Transformation Branch at UNFPA.
All resources in this hub
-404x270.webp)
10 min read
From commitment to capability: Are current R&D trends delivering on Africa’s health sovereignty ambitions?
The first publication in the R&D Blindspots Policy Series examines a pressing question for the continent: is research and development truly delivering Africa’s vision for health security and sovereignty?
Impact Global Health and PATH29 Apr 2026
5 min read
UK backs one in five malaria tools in development - as campaigners warn “malaria science superpower” status must be maintained
New research shows UK institutions are involved in R&D for 20% of malaria tools currently in the pipeline – the third highest of any country
5 min read
Compass has expanded: real-time R&D funding data now covers emerging infectious diseases and women's health
Tom Clifton shares how our Compass tool can help you spot funding trends the moment they emerge.
-404x404.webp)
10 min read
Health R&D financing in Africa: Towards resilience, innovation, and sovereignty
This brief outlines the current state of health R&D financing in Africa and underscores the importance of sustained, country-led investment amid declining global funding.
15 min read
Funding for global health R&D in 2024
An overview of key takeaways from the G-FINDER survey
10 min read
R&D funding for neglected diseases remained stable at $4.3bn in 2024
Dr Paul Barnsley summarises the 2024 funding landscape for neglected diseases.
20 min read
State of disunion: The impact of US funding cuts on global health R&D
This report offers a quantified assessment of the actual and potential impact of the 2025 US funding cuts giving a system-wide, data-driven picture of the ripple effects by disease, product, research stage, and sector.
20 min read
Mapping the Australian landscape for global health research
This is an in-depth analysis of Australia’s public sector funding for global health research from 2017 to 2023. As a high-income country, Australia has the potential to play a significant role in addressing global health challenges, especially within the Indo-Pacific region. The report highlights both the strengths and gaps in Australia’s global health research funding.
45 min read
A New Era? Funding for sexual & reproductive health R&D 2018-2023
This is the fourth in a series of reports summarising the state of global funding for LMIC-applicable biomedical research and development targeting a range of sexual & reproductive health and women’s health issues
...